139 related articles for article (PubMed ID: 9822927)
1. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.
McCluggage WG; Shanks JH; Arthur K; Banerjee SS
Histopathology; 1998 Oct; 33(4):361-8. PubMed ID: 9822927
[TBL] [Abstract][Full Text] [Related]
2. Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors.
Cheville JC; Sebo TJ; Lager DJ; Bostwick DG; Farrow GM
Am J Surg Pathol; 1998 Nov; 22(11):1361-7. PubMed ID: 9808128
[TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid flow cytometry of testicular Leydig cell tumors.
Palazzo JP; Petersen RO; Young RH; Scully RE
J Urol; 1994 Aug; 152(2 Pt 1):415-7. PubMed ID: 8015084
[TBL] [Abstract][Full Text] [Related]
4. A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract.
Cooper PN; Quirke P; Hardy GJ; Dixon MF
Am J Surg Pathol; 1992 Feb; 16(2):163-70. PubMed ID: 1733349
[TBL] [Abstract][Full Text] [Related]
5. Cellular schwannoma. A clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients.
Casadei GP; Scheithauer BW; Hirose T; Manfrini M; Van Houton C; Wood MB
Cancer; 1995 Mar; 75(5):1109-19. PubMed ID: 7850709
[TBL] [Abstract][Full Text] [Related]
6. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry.
Prayson RA
Am J Clin Pathol; 1996 Jun; 105(6):719-26. PubMed ID: 8659446
[TBL] [Abstract][Full Text] [Related]
7. Leydig cell tumor of the testis: comparison of histopathological and immunohistochemical features of three azoospermic cases and one malignant case.
Hekimgil M; Altay B; Yakut BD; Soydan S; Ozyurt C; Killi R
Pathol Int; 2001 Oct; 51(10):792-6. PubMed ID: 11881732
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumours.
Sarli G; Benazzi C; Preziosi R; Marcato PS
J Comp Pathol; 1994 May; 110(4):357-68. PubMed ID: 7914524
[TBL] [Abstract][Full Text] [Related]
9. Leydig cell tumor of the testis. Morphological and endocrinological investigations in two cases.
Mikuz G; Schwarz S; Höpfel-Kreiner I; Greber F
Eur Urol; 1980; 6(5):293-300. PubMed ID: 7398702
[TBL] [Abstract][Full Text] [Related]
10. Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases.
Lerma E; Oliva E; Tugués D; Prat J
Virchows Arch; 1994; 424(1):19-24. PubMed ID: 7981899
[TBL] [Abstract][Full Text] [Related]
11. alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
Spermon JR; De Wilde PC; Hanselaar AG; Schaafsma HE; Ruijter TE; Witjes JA; Van Moorselaar RJ
BJU Int; 2002 Feb; 89(3):278-84. PubMed ID: 11856111
[TBL] [Abstract][Full Text] [Related]
12. Testicular seminoma: clinical significance of nuclear deoxyribonucleic acid ploidy pattern as studied by flow cytometry.
Mor Y; Leibovich I; Raviv G; Nass D; Medalia O; Goldwasser B; Nativ O
J Urol; 1995 Sep; 154(3):1041-3; discussion 1044. PubMed ID: 7637050
[TBL] [Abstract][Full Text] [Related]
13. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
[TBL] [Abstract][Full Text] [Related]
14. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
Kocová L; Skálová A; Fakan F; Rousarová M
Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
16. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):215-21. PubMed ID: 11556748
[TBL] [Abstract][Full Text] [Related]
17. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
[TBL] [Abstract][Full Text] [Related]
18. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
19. Cytometric analysis of testicular seminoma and spermatocytic seminoma.
Takahashi H
Acta Pathol Jpn; 1993 Mar; 43(3):121-9. PubMed ID: 8484333
[TBL] [Abstract][Full Text] [Related]
20. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature.
Kim I; Young RH; Scully RE
Am J Surg Pathol; 1985 Mar; 9(3):177-92. PubMed ID: 3993830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
